• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Marathon Oil Corporation

    12/2/24 4:30:46 PM ET
    $MRO
    Oil & Gas Production
    Energy
    Get the next $MRO alert in real time by email
    15-12G 1 tm2429862d1_1512g.htm 15-12G

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

     

    FORM 15

     

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
    12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
    REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

     

    Commission File Number 001-05153

     

    MARATHON OIL CORPORATION
    (Exact name of registrant as specified in its charter)
     

    c/o ConocoPhillips

    Kelly B. Rose

    925 N. Eldridge Parkway

    Houston, Texas 77079

    (281) 293-1000

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
     

    Common Stock, par value $1.00 per share

    4.400% Senior Notes due 2027

    5.300% Senior Notes due 2029

    6.800% Senior Notes due 2032

    5.700% Senior Notes due 2034

    6.600% Senior Notes due 2037

    5.200% Senior Notes due 2045

    (Title of each class of securities covered by this Form)
     
    None
    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

      Rule 12g-4(a)(1) x
      Rule 12g-4(a)(2) ¨
      Rule 12h-3(b)(1)(i) x
      Rule 12h-3(b)(1)(ii) ¨
      Rule 15d-6 ¨
      Rule 15d-22(b) ¨

     

    Approximate number of holders of record as of the certification or notice date*:

     

    ·Common Stock, par value $1.00 per share: 1

    ·4.400% Senior Notes due 2027: 78

    ·5.300% Senior Notes due 2029: 61

    ·6.800% Senior Notes due 2032: 64

    ·5.700% Senior Notes due 2034: 66

    ·6.600% Senior Notes due 2037: 68

    ·5.200% Senior Notes due 2045: 61

     

    *As previously disclosed, on May 28, 2024, Marathon Oil Corporation (the “Company”) entered into an Agreement and Plan of Merger (“Merger Agreement”) by and among ConocoPhillips (“ConocoPhillips”), a Delaware corporation, Puma Merger Sub Corp. (“Merger Sub”), a Delaware corporation and wholly owned subsidiary of ConocoPhillips, and the Company. On November 22, 2024, upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub merged with and into the Company, with the Company continuing as the surviving entity and wholly owned subsidiary of ConocoPhillips. This Form 15 relates solely to the reporting obligations of the Company.

     

     

     

     

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Marathon Oil Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

     MARATHON OIL CORPORATION
       
    By:/s/ Kelly B. Rose
    Name:Kelly B. Rose
    Title:Senior Vice President, Legal, General Counsel and Corporate Secretary

     

    Date: December 2, 2024

     

     

    Get the next $MRO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MRO

    DatePrice TargetRatingAnalyst
    7/12/2024$45.00 → $29.00Sector Outperform → Sector Perform
    Scotiabank
    4/10/2024$35.00Overweight
    Barclays
    3/14/2024$31.00Hold → Buy
    Argus
    12/11/2023$27.00 → $25.00Overweight → Equal-Weight
    Morgan Stanley
    7/12/2023$25.00Sell → Neutral
    Goldman
    4/19/2023$33.00Buy
    UBS
    3/23/2023$27.00Neutral → Buy
    Citigroup
    2/16/2023$32.00Hold → Buy
    The Benchmark Company
    More analyst ratings